Literature DB >> 26156656

The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma.

Lauren M Postlewait1, Malcolm H Squires1, David A Kooby1, George A Poultsides2, Sharon M Weber3, Mark Bloomston4, Ryan C Fields5, Timothy M Pawlik6, Konstantinos I Votanopoulos7, Carl R Schmidt4, Aslam Ejaz6, Alexandra W Acher3, David J Worhunsky2, Neil Saunders4, Douglas Swords7, Linda X Jin5, Clifford S Cho3, Emily R Winslow3, Kenneth Cardona1, Charles A Staley1, Shishir K Maithel8.   

Abstract

BACKGROUND: Conflicting data exist on the prognostic implication of signet-ring cell (SRC) histology in gastric adenocarcinoma (GAC).
METHODS: All patients who underwent curative-intent resection of GAC from the seven institutions of the U.S. Gastric Cancer Collaborative between 2000 and 2012 were included. Primary end points were recurrence-free survival (RFS) and overall survival (OS). Stage-specific analyses were performed.
RESULTS: A total of 768 patients met the inclusion criteria. SRC was present in 40.6 % of patients and was associated with female sex (52.9 vs. 38.6 %; p < 0.001), younger age (61 vs. 67 years; p < 0.001), poor differentiation (94.8 vs. 50.3 %; p < 0.001), perineural invasion (PNI) (41.4 vs. 23 %; p < 0.001), microscopically positive resection margins (R1, 24.7 vs. 8.6 %; p < 0.001), distal location (82.2 vs. 70.1 %; p < 0.001), receipt of adjuvant therapy (63 vs. 51.2 %; p = 0.002), and more advanced stage (stage 3: 55.2 vs. 36.5 %; p < 0.001). SRC was associated with earlier recurrence (56.7 months vs. median not reached; p = 0.009) and decreased OS (33.7 vs. 46.6 months; p = 0.011). When accounting for other adverse pathologic features, PNI (hazard ratio [HR] 1.57; p = 0.016) and higher stage (HR 2.64; p < 0.001) were associated with decreased RFS, but SRC was not. Although PNI (HR 1.52; p = 0.007), higher stage (HR 2.11; p < 0.001), greater size (HR 1.05; p = 0.016), and adjuvant therapy (HR 0.50; p < 0.001) were associated with OS, SRC was not. Similarly, when accounting for adverse pathologic factors on multivariate analysis, stage-specific analyses showed no association between SRC and RFS or OS.
CONCLUSIONS: SRC histology is associated with adverse pathologic features including poor differentiation, higher stage, and microscopically positive resection margins but is not independently associated with reduced RFS or OS. Identification of signet-ring histology during preoperative evaluation should not, in isolation, dictate treatment strategy.

Entities:  

Mesh:

Year:  2015        PMID: 26156656     DOI: 10.1245/s10434-015-4724-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  12 in total

1.  Evaluating TNM stage prognostic ability in a population-based cohort of gastric adenocarcinoma patients in a low-incidence country.

Authors:  Alyson L Mahar; Brandon Zagorski; Daniel Kagedan; Matthew Dixon; Abraham El-Sedfy; Jovanka Vasilevska-Ristovska; Daniela Cortinovis; Corwyn Rowsell; Calvin Law; Lucy Helyer; Lawrence Paszat; Natalie Coburn
Journal:  Can J Public Health       Date:  2018-08-08

2.  Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric Cancer.

Authors:  Pengfei Kong; Ruiyan Wu; Chenlu Yang; Qirong Geng; Jianjun Liu; Shangxiang Chen; Xuechao Liu; Minting Ye; Wenzhuo He; Qiong Yang; Liangping Xia; Dazhi Xu
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

3.  Prognostic value of differentiation status in gastric cancer.

Authors:  Fan Feng; Jinqiang Liu; Fei Wang; Gaozan Zheng; Qiao Wang; Shushang Liu; Guanghui Xu; Man Guo; Xiao Lian; Hongwei Zhang
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

4.  Prognostic Nomograms for Nonelderly Adults with Gastric Signet Ring Cell Carcinoma.

Authors:  Hui Wang; Yao Peng; Qi Huang; Jingjing Wu; Mingjun Zhang
Journal:  Biomed Res Int       Date:  2021-03-24       Impact factor: 3.411

Review 5.  Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges.

Authors:  Naveena A N Kumar; Anmi Jose; Nawaz Usman; Keshava Rajan; Murali Munisamy; Preethi S Shetty; Mahadev Rao
Journal:  Langenbecks Arch Surg       Date:  2021-09-10       Impact factor: 2.895

Review 6.  Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis.

Authors:  Cristina Díaz Del Arco; Luis Ortega Medina; Lourdes Estrada Muñoz; Soledad García Gómez de Las Heras; Mª Jesús Fernández Aceñero
Journal:  Histol Histopathol       Date:  2021-02-10       Impact factor: 2.303

7.  Prognosis and Biological Behavior of Gastric Signet-Ring Cell Carcinoma Better or Worse: A Meta-Analysis.

Authors:  Shuai Zhao; Ling Lv; Kai Zheng; Yu Tian; Jian-Chun Zheng; Cheng-Gang Jiang
Journal:  Front Oncol       Date:  2021-06-30       Impact factor: 6.244

8.  Clinicopathological Characteristics and Prognostic Value of Signet Ring Cells in Gastric Carcinoma: A Meta-Analysis.

Authors:  Run-Cong Nie; Shu-Qiang Yuan; Yuan-Fang Li; Yong-Ming Chen; Xiao-Jiang Chen; Bao-Yan Zhu; Li-Pu Xu; Zhi-Wei Zhou; Shi Chen; Ying-Bo Chen
Journal:  J Cancer       Date:  2017-09-20       Impact factor: 4.207

9.  Prognostic significance of poorly cohesive gastric carcinoma in Tunisian patients.

Authors:  Raja Jouini; Fatma Khanchel; Meriam Sabbah; Imen Helal; Abdessalem Gharsallah; Marwa Ferchichi; Dhafer Hadded; Haithem Zaafouri; Ehsen Ben Brahim; Anis Ben Maamer; Aschraf Chadli Debbiche
Journal:  Heliyon       Date:  2020-03-14

10.  A novel nomogram for predicting survival of patients with poorly differentiated gastric adenocarcinoma.

Authors:  Xiaolu Zhou; Zhiyuan Dong; Chenjing Zhang; Xiaoge Geng; Lunan Li; Jiyong Jing; Wensheng Pan; Haifang Lou
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.